Leiden, Netherlands

Jan Wouter Drijfhout

USPTO Granted Patents = 25 


 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Jan Wouter Drijfhout: Innovator in Bioactive Peptides

Introduction

Jan Wouter Drijfhout, based in Leiden, Netherlands, is a notable inventor with an impressive portfolio of 25 patents. His innovative work centers around bioactive peptides derived from snakes, which hold significant potential for medicinal applications.

Latest Patents

Among his latest innovations, Drijfhout has disclosed bioactive peptides derived from snakes. These peptides are specifically designed to inhibit bacterial, fungal, viral, and parasitic infections. Additionally, they offer promising applications in the treatment of inflammatory conditions and cancers. The dual utility of these peptides marks a significant advancement in the field of biomedical research.

Career Highlights

Drijfhout has had a productive career, contributing his expertise at reputable institutions such as Academisch Ziekenhuis Leiden, commonly known as LUMC, and the Ludwig Institute for Cancer Research Limited. These affiliations have allowed him to collaborate on groundbreaking research and develop his patented inventions further.

Collaborations

Throughout his career, Drijfhout has worked closely with esteemed colleagues, including Yao-tseng Chen and Matthew J. Scanlan. Their collaborative efforts have undoubtedly played a role in the successful development of his innovative ideas and patents.

Conclusion

Jan Wouter Drijfhout's contributions to the field of bioactive peptides represent a valuable addition to medical science. His extensive patent portfolio highlights his commitment to innovation and the meaningful impact his work may have on treating various health conditions. As his research continues to evolve, Drijfhout remains a prominent figure in the exploration of snake-derived peptides for therapeutic purposes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…